Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) largely express an alternatively activated (or M2) phenotype, which entails immunosuppressive and tumour-promoting capabilities. Reprogramming TAMs towards a classically activated (M1) phenotype may thwart tumour-associated immunosuppression and unleash anti-tumour immunity. Here we show that conditional deletion of the microRNA (miRNA)-processing enzyme DICER in macrophages prompts M1-like TAM programming, characterized by hyperactive IFN-γ/STAT1 signalling. This rewiring abated the immunosuppressive capacity of TAMs and fostered the recruitment of activated cytotoxic T lymphocytes (CTLs) to the tumours. CTL-derived IFN-γ exacerbated M1 polarization of Dicer1-deficient TAMs and inhibited tumour growth. Remarkably, DICER deficiency in TAMs negated the anti-tumoral effects of macrophage depletion by anti-CSF1R antibodies, and enabled complete tumour eradication by PD1 checkpoint blockade or CD40 agonistic antibodies. Finally, genetic rescue of Let-7 miRNA activity in Dicer1-deficient TAMs partly restored their M2-like phenotype and decreased tumour-infiltrating CTLs. These findings suggest that DICER/Let-7 activity opposes IFN-γ-induced, immunostimulatory M1-like TAM activation, with potential therapeutic implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Macrophages have been shown to be plastic [334,335,336].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [334]
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Cited by
Items 201–260 of 260
Zhang, H., Liu, Y., Liu, W., Lin, A., Fang, Y., Qu, L., Zhang, X., Luo, P., Wang, L., & Jiang, A. (2025) · Biomarker Research · doi:10.1186/s40364-025-00811-0 · Cited by 9
Non-coding RNAs in lipid metabolism and their roles in atherosclerosis
Sallam, T., Solingen, C. V., & Moore, K. J. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01229-9 · Cited by 10
Wu, Z., & Ju, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.888276 · Cited by 9
“1 miRNAs in TME miRNA is a type of small ncRNA that can bind to 3’-untranslated regions (3’-UTRs) or amino acid coding sequences to regulate mRNA expression (31).”
BackgroundVizcaino-Castro, A., Daemen, T., & Oyarce, C. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106864 · Cited by 12
Zhu, L., Li, Z., Dong, X., Wu, H., Cheng, Y., Xia, S., Bao, X., Xu, Y., & Cao, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01571-4 · Cited by 9
Effective design of therapeutic nanovaccines based on tumor neoantigens
Wang, W., Zhai, Y., Yang, X., Ye, L., Lu, G., Shi, X., & Zhai, G. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.078 · Cited by 9
Micro RNAs are required for Langerhans cell, skin- and lung-resident macrophage ontogeny
Yao, Y., Martin, C. E., Yin, C., Guo, C., Dong, Z., Zhou, L., & Mi, Q. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.024 · Cited by 8
Tumor-macrophage crosstalk: how to listen
Dey, T. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa023 · Cited by 9
Cismaru, C. A., Pîrlog, R., Călin, G. A., & Berindan‐Neagoe, I. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10428-7 · Cited by 8
“MiR-181a, miR146b, and mmu-let-7c/d [133, 134] for instance, promote M2 and suppress M1 activation at the same time.”
BackgroundBresesti, C., Carito, E., Notaro, M., Giacca, G., Breggion, S., Kerzel, T., Mercado, C. M., Beretta, S., Monti, M., Merelli, I., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115592 · Cited by 9
Self-citationRen, X., Yuan, W., Ma, J., Wang, P., Sun, S., Wang, S., Zhao, R., & Liang, X. (2022) · Biomaterials Science · doi:10.1039/d1bm01770e · Cited by 7
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
Gramantieri, L., Fornari, F., Giovannini, C., & Treré, D. (2022) · Biomolecules · doi:10.3390/biom12070930 · Cited by 7
“In the context of innate immunity, the conditional deletion of Dicer in tumor-associated macrophages (TAM) promotes an M2 to M1 phenotypic change, rewiring the immunesuppressive functions to antitumor immune response, via IFN-gamma/STAT1 signaling [44].”
BackgroundMacrophage interference on chemotherapy
Palma, M. D., Nassiri, S., & Cianciaruso, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0303-8 · Cited by 7
You, J., Lee, C., Lee, Y.-S., Chern, Y., Liao, C., & Hsu, H. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102198 · Cited by 6
“Beyond their direct cytotoxic effects, NK cells also indirectly suppress cancer progression through IFN-γ -mediated regulation of other innate and adaptive immune cells, such as macrophages and T cells [30,31].”
Yang, Q., Shu, Y., Chen, Y., Qi, Z., Hu, S., Zhang, Y., Yu, Q., Xu, X., Hu, J., Huang, A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1513555 · Cited by 9
Critical appraisal of epigenetic regulation of galectins in cancer
Gadwal, A., Modi, A., Khokhar, M., Vishnoi, J. R., Choudhary, R., Elhence, P. A., Banerjee, M., & Purohit, P. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02048-x · Cited by 6
“There are several studies which show that modulating miRNA expression is also a promising approach for immunotherapy in cancer [46].”
BackgroundKiss, M., Lebegge, E., Murgaski, A., Damme, H. V., Kancheva, D., Brughmans, J., Scheyltjens, I., Talebi, A., Awad, R. M., Elkrim, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1003975 · Cited by 7
“Both tumor models have been shown to rely on the recruitment of monocytes and neutrophils for their progression (30, 36, 37).”
BackgroundSelf-citationLu, S., Peng, X., Zeng, S., Deng, H., Feng, Z., Zeng, Q., Cheng, X., Hu, J., Ye, Z., Li, M., et al. (2021) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2021.104216 · Cited by 5
Cai, Y., Jia, Y., Yan, P., Chang, X., Li, W., & Cai, B. (2022) · Protein and Peptide Letters · doi:10.2174/0929866529666220823161842 · Cited by 5
Jacenik, D., Lebish, E. J., & Beswick, E. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212100 · Cited by 5
Arthanareeswaran, V., Berndt‐Paetz, M., Ganzer, R., Stolzenburg, J., Ravichandran-Chandra, A., Glasow, A., & Neuhaus, J. (2018) · Laparoscopic Endoscopic and Robotic Surgery · doi:10.1016/j.lers.2018.01.001 · Cited by 5
Martino, M. T. D., Zazzeroni, F., Donadelli, M., Chiodoni, C., Caraglia, M., Scotlandi, K., Meschini, S., & Leonetti, C. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0710-x · Cited by 5
“All together the provocative findings presented by De Palma support the hypothesis that the reprogramming of TAMs to an immunostimulatory mode can synergize with several anti-cancer therapies that, either directly or indirectly, may enhance the endogenous immune response against the tumor [2].”
Liu, Y., Luo, M., Shi, Y., Guo, Y. J., Zhang, H., Yang, K., Li, T., Yang, L., Liu, T., Huang, B., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02393-9 · Cited by 4
“The pro-inflammatory macrophages further activated tumor infiltrated T cells and enhanced the efficiency of anti-CSF1R antibodies, PD1 and CD40 blockade against mice breast and lung cancer [22].”
Neutrophil-modulated Dicer expression in macrophages influences inflammation resolution
Wang, Z., Li, W., Li, J., Jin, T., Chen, H., Liang, F., Liu, S., Jia, J., Liu, T., Liu, Y., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05644-6 · Cited by 4
“Studies have shown that inhibiting Dicer activity or deleting Dicer enhances pro-inflammatory responses in macrophages and induces a M1-like programming in tumor-associated macrophages (TAM) [19, 20].”
Xu, Y., Feng, W., Liu, Y., Hua, G., Li, J., Zhou, J., & Tang, Y. (2025) · Aquaculture International · doi:10.1007/s10499-025-02068-8 · Cited by 2
“MiR-315 in Drosophila melanogaster acts as a specific activator of the wingless signaling pathway, playing a role in the regulation of wing development (Baer et al. 2016; Wang et al. 2023; Yuan et al. 2020).”
Tumor-Associated Macrophages in Colorectal Cancer
Amălinei, C., Costin, C. A., Grigoraş, A., Chifu, M.-B., & Pricope, D. L. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_238 · Cited by 2
Schafer, F., Bellolio, E. R., Sepúlveda, T., Espinoza, M., Orellana, J., Bellolio, I., Villaseca, M., & Miranda, R. (2025) · Experimental Dermatology · doi:10.1111/exd.70110 · Cited by 2
“Also, other studies have shown that the deletion of Dicer in macrophages and embryonic stem cells promoted antitumour immunity through IFN-γ signalling [31, 32].”
The Contribution of Immune Cells to Angiogenesis in Inflammation and Tumor Growth
Ribatti, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-68448-2_7 · Cited by 3
miRNAs: the genetic regulators of immunity
Ali, S., Khan, M. S., Wani, J. A., Faiz, S., Rehman, M. U., Majid, S., & Ali, M. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00003-8 · Cited by 2
DICERing macrophages for reprogramming TAMs
Squadrito, M. L., & Palma, M. D. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1216927 · Cited by 2
Self-citationShalova, I. N., Saha, S., & Biswas, S. K. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch9 · Cited by 2
DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria
Killy, B., Bodendorfer, B., Mages, J., Ritter, K., Schreiber, J., Hölscher, C., Pracht, K., Ekici, A. B., Jäck, H., & Lang, R. (2021) · Life Science Alliance · doi:10.26508/lsa.202000810 · Cited by 1
“For instance, expression of TLR2 and TLR4 are controlled by miR-19 and let7e, respectively (Philippe et al, 2012; Curtale et al, 2018). miR-146a curbs innate immune responses by down-regulating critical TLR signaling components (Hou et al, 2009; Nahid et al, 2016). miR-146a targets STAT1 and IRF5 and thereby suppresse…”
BackgroundMethodInfluentialGlobal research trends in tumor-associated macrophage studies: a bibliometric analysis
Luan, A., Zhang, Y., Lu, Y., Zhao, G., & Yang, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02473-8 · Cited by 2
Uncoupling neocortical neuron fate and migration via a Let-7–RBX2 axis
Decker, S. C., Hino, K., Torre, A. L., & Simó, S. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528396123 · Cited by 1
Sayed, U., Abdulsahib, W. K., Jyothi, S. R., Nayak, P. P., Chauhan, A. S., Singla, S., Polatova, D. S., Sead, F. F., & Akhavan‐Sigari, R. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-02027-w · Cited by 1
Wang, Y., Wang, Y., Wu, R., Luo, H., Li, Y., Chen, X., Liu, K., Dong, Z., & Liu, H. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102096 · Cited by 1
Micromanaging Inflammation and Tissue Repair
Das, A., & Roy, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820719-2.00021-1 · Cited by 1
Djaldetti, M. (2017) · Journal of Immunology and Serum Biology · doi:10.15436/2471-5891.17.1277 · Cited by 1
Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer
Holvoet, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-68844-8_7 · Cited by 1
Role of Tumour-Associated Macrophages in Colon Cancer Progression and Its Therapeutic Targeting
Mehta, A., Soni, V. K., Ratre, Y. K., Amit, A., Shukla, D., Kumar, A., & Vishvakarma, N. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-72702-4_10 · Cited by 1
FSC certification in Zambia's miombo woodlands: the experience of Muzama.
Robertson, B. (2000) · Cited by 1
[Research progress of bone marrow microenvironment abnormalities in myelodysplastic syndrome].
Dong, P., Huang, L., & Sun, H. Y. (2017) · PubMed · doi:10.3760/cma.j.issn.0253-2727.2017.07.022
Does Iron Modulate Cytokine Production by Desferrioxamine Treated Mononuclear Cells?
Bessler, H., & Djaldetti, M. (2018) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2018.108.114
“Furthermore, it has been shown that IFNγ stimulates M1 activation resulting in decreased immune activity of M2 cells which are tumor associated macrophages (Baer et al., 2016).”
BackgroundPTP4A2 regulates Sorafenib resistance via activating autophagy in hepatocellular carcinomaPreprint
Chen, D., He, Y., Zhou, M., Gao, Y. H., Zheng, Z., Ye, W., Xie, D., Zhang, J., & Ye, S. (2020) · Research Square · doi:10.21203/rs.3.rs-66927/v1
Galliverti, G., Tichet, M., Domingos‐Pereira, S., Hauert, S., Nardelli‐Haefliger, D., Swartz, M. A., Hanahan, D., & Wullschleger, S. (2023) · doi:10.1158/2326-6066.c.6548929
The immune landscape of tumor-associated macrophage reprogrammingPreprint
Duval, F., Lourenço, J., Hicham, M., Boivin, G., Guichard, A., Wyser-Rmili, C., Fournier, N., Palma, M. D., & Mansouri, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.25.614962
“We and others have previously reported that mice with an inactivating mutation in the miRNA-processing enzyme, Dicer1 , specifically in myeloid cells exhibit delayed tumor growth in multiple cancer models 11,12 .”
BackgroundMethodResultInfluentialDesponds, E., Ahanidi, H. E., Alouche, N., Zdimerova, H., Favre, S., Zanette, G., Nassiri, S., Benamran, D. A., Tsantoulis, P. K., Attaleb, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.21.644543
Yang, L., Li, F., Cao, Y., Liu, Q., Jing, G., Niu, J., Sun, F., Qian, Y., Wang, S., & Li, A. (2021) · Figshare · doi:10.6084/m9.figshare.16829392
Jia, W., Luo, S., Gena, L., Li, S., Huo, S., Li, M., & Zeng, X. (2021) · Figshare · doi:10.6084/m9.figshare.14676967
Jia, W., Luo, S., Gena, L., Li, S., Huo, S., Li, M., & Zeng, X. (2021) · Figshare · doi:10.6084/m9.figshare.14676973
Jia, W., Luo, S., Gena, L., Li, S., Huo, S., Li, M., & Zeng, X. (2021) · Figshare · doi:10.6084/m9.figshare.14676970
Zhu, L.-W., Li, Z., Dong, X., Wu, H., Cheng, Y., Xia, S., Bao, X., Xu, Y., & Cao, R. (2024) · Figshare · doi:10.6084/m9.figshare.25834107
Liu, L., Gao, J., Xing, X., Jiang, M., Liu, Q., Wang, S., & Luo, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26557289
CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma
Yu, Z., Wang, X., Zheng, Y., He, Y., Lin, J., Xiao, Y., Mo, B., Xie, H., Hang, S., Gao, X., et al. (2026) · Non-coding RNA Research · doi:10.1016/j.ncrna.2026.03.003
Activation des lymphocytes T gamma delta dans les cancers
Laplagne, C. (2020) · theses.fr (ABES) · doi:10.70675/7f8ae6ddz0e42z4c41z838fz044b72328b9c
Implication du gène Dicer1 dans le vieillissement et ses pathologies chez la souris
de Cauwer, A. (2020) · theses.fr (ABES) · doi:10.70675/22c08094z1342z429fza3fez5ff6b78d1481
Characterization of a novel antibody targeting tumor-associated macrophages
Domagala, M. (2022) · theses.fr (ABES) · doi:10.70675/b4720b22z5236z4e41za89dz1f8d16c27670
Etude des mécanismes de contrôle des cellules tumorales par les cellules Natural Killer
Fenis, A. (2024) · theses.fr (ABES) · doi:10.70675/747c59caz7a79z4064z989cz9dd2bc8bd27e
Mayeaux, M. A., Zhou, X., & Rafat, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.14.751444
Hirt, N., Manchon, E., Wu, M., Buanec, H. L., Bataille, P., Bourrat, E., Bouaziz, J., Jabrane‐Ferrat, N., & Al‐Daccak, R. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70315
“…the let-7 and miR-154 families, which were highly enriched in our EVT-EVs, are known to downregulate pro-inflammatory transcripts while promoting anti-inflammatory gene expression, supporting the acquisition of a regulatory monocyte phenotype (Baer et al. 2016 ; Lv et al. 2024 ; Yang et al. 2024 ).”
Metadata
- Authors
- Baer, C., Squadrito, M. L., Laoui, D., Thompson, D., Hansen, S. K., Kiialainen, A., Hoves, S., Ries, C. H., Ooi, C.-H., & De Palma, M.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- F. Hoffmann-La Roche AG (CH)
- Roche Pharma AG (Germany) (DE)
- Corresponding author
- Squadrito, Mario Leonardo
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2016-06-13
- Volume
- 18
- Issue
- 7
- Pages
- 790-802
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2436603111
- Cited by
- 259
- References
- 71
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 24 · 2023: 15 · 2022: 37 · 2021: 36 · 2020: 35 · 2019: 26 · 2018: 32 · 2017: 20 · 2016: 8
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- tumour-associated macrophages, microRNA processing, Dicer, let-7 microRNA, M1 macrophage polarization, M2 macrophage phenotype, antitumor immunity, cytotoxic T lymphocytes, anti-PD-1 therapy, CSF1R blockade, macrophage depletion, tumor immunosuppression
- MeSH terms
- Animals, Cells, Cultured, Humans, Interferon-gamma, Macrophage Activation, Macrophages, Neoplasms, MicroRNAs, Ribonuclease III, Mice, DEAD-box RNA Helicases, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.